Participated · Equity · Jul 2026

Hyperion Robotics combines robotics, automation and artificial intelligence to manufacture infrastructure components in factory settings located close to project sites. Its Forge platform integrates design, structural engineering, code compliance, robotics and factory operations into a single system that controls its robotic microfactories. The company says its approach can produce components up to three times faster, reduce costs by up to 50%, cut carbon emissions by up to 70% and use up to 75% less material compared with conventional construction methods. With the new funding, Hyperion plans to scale microfactories across Europe and launch Forge I, its first UK facility in Flixborough near Scunthorpe, in partnership with LKAB. The company intends to serve sectors including energy, utilities, water, data centres and carbon capture while continuing development of the Forge platform.

Participated · Seed · Jun 2026

Companion.energy operates a platform that unifies energy contracts, live operational data, and distributed assets to continuously forecast demand, track market exposure, and automatically execute energy decisions. The company positions its software as a system of execution rather than a monitoring dashboard, directing assets to times of lower prices or profitable grid sales. Founded in 2022, the 19-person startup reports more than €1M in annual recurring revenue after tenfold growth since May 2024 and serves major customers including TotalEnergies, KPN, the Port of Antwerp–Bruges, Interparking, and Proximus Group. It now manages over 2 TWh of annual energy use and supports more than 200 MW of distributed solar, wind, batteries, and EV charging assets. Companion.energy plans to use its recent funding to enhance multi-asset, multi-market optimisation and to expand into Germany and Spain.

Participated · Equity · Dec 2025

Founded in 2023 by ex-Lydia executives Maxime Bensadoun and Victor Jolly, ECAIR acts as a financial co-pilot for installers undertaking energy-transition projects. Its platform converts quotations into fully funded projects by offering an integrated capital stack that spans installer working capital and point-of-sale consumer loans. The newly launched consumer-loan product uses an AI-driven underwriting engine that calibrates repayments to a home’s projected energy savings, making projects cash-flow positive from day one. On the B2B side, ECAIR has already deployed more than €8 million in working capital to installers. With electricity prices up 80% and gas 120% in France over the past decade, the company targets a €15 billion French residential renovation market and a €100 billion opportunity across the EU. Proceeds from its latest funding will accelerate product rollout and support expansion across France before scaling further into Europe.

Participated · Series A · Oct 2025

Founded in 2020 as an ETH Zurich spin-off, Exnaton develops a white-label software platform that automates billing and analytics for renewable-energy products. The AI-driven system supports dynamic tariffs, peer-to-peer energy sharing, and smart electric-vehicle charging, allowing utilities to launch and manage new energy offerings quickly. Headquartered in Zurich, the company already serves more than 50 utilities across Europe, including TotalEnergies in Belgium and Bayernwerk in Germany. Exnaton positions itself as a critical infrastructure layer for utilities transitioning to decentralized, data-heavy energy models. With fresh capital, it plans to deepen its AI capabilities and broaden feature sets that help clients monetize distributed energy resources. The firm also intends to accelerate geographic expansion within Europe and scale its commercial and technical operations. No revenue figures were disclosed in the article.

Participated · Seed · Feb 2025

ZYMVOL develops computational methods for enzyme discovery and design using highly realistic simulations that mimic experimental conditions with over 90% accuracy. Its platform reduces development time and cost by allowing only the most promising variants to proceed to lab testing, and it can discover enzymes for a target reaction without prior data. Founded in 2017, the company has completed more than 100 projects, primarily for pharmaceutical and chemical clients including Axplora, Medichem, and Sanofi. Over the years it has partnered with R&D teams from some of the world’s largest firms to transform production processes and reduce environmental impact through tailored enzymatic solutions. CEO Maria Fátima Lucas says ZYMVOL aims to make enzymes accessible to everyone so green chemistry becomes the new norm. The company positions its technology as a way to boost innovation and strengthen industrial resilience across sectors. Zymvol designs and develops enzymes using highly realistic computer simulations of enzyme environments rather than relying solely on laboratory work. Its computational approach accelerates development by up to 50%, lowers costs, and yields a success rate above 75%. The company sells B2B services including prospect studies and full discovery, optimization, and laboratory validation for chemical, pharmaceutical and biotech clients. Zymvol aims to make enzymes accessible to companies seeking more efficient products and more sustainable processes, including reducing toxic waste through enzyme customization. The 28-person team is led by Dr. Maria Fatima Lucas, who has over 20 years of experience in protein science and computational chemistry; the company was founded in 2017. Recent financing is intended to grow the team, develop its new laboratory, scale production and validate the performance of its biomelanin. Zymvol uses computer simulations to discover and develop industrial enzymes. Its core product is a platform that models challenging factory-floor environments to engineer enzymes that tolerate pressure and temperature variations. The company says its simulations can achieve results in roughly half the time and at lower cost than traditional lab engineering. Zymvol also claims the approach can identify enzymes for a target reaction without prior knowledge, enabling serendipitous discoveries. Target markets include pharma, chemical and food industries and consumer products such as detergents, where enzymes can replace less sustainable catalysts and improve product properties. To accelerate discovery and development of new industrial enzymes, Zymvol raised €1.3 million in seed funding from Elaia Partners.